Trial · NCT07205757
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | incidence of ventricular fibrillation (VF) | Perioperative | incidence of VF occurring after Aorta cross-clamp (ACC) removal |
| Secondary | Troponin I (µg/L) | At immediate postoperatively, 12 and 24 hours postoperative | Troponin I to assess myocardial protection between the two cardioplegia solutions used. |
| Secondary | Number of defibrillator shocks | Perioperative | shocks required to terminate ventricular arrhythmia after ACC removal |
| Secondary | Total volume of cardioplegia solution (in ml). | Perioperative | cardioplegia volume given to the patient |
| Secondary | Total cross-clamp time | from cross clamp until removal of aorta cross clamp up to 6 hours | in minutes |
| Secondary | total CPB time | from starting CPB until weaning from bypass is completed up to 6 hours | in minutes |
| Secondary | Number of grafts | at the end of surgery up to 6 hours | anastomosis coronary grafts |
| Secondary | Time taken to cardiac arrest after cardioplegia infusion | from the start of cardioplegia administration until asystole up to one hour | time to asystole |
| Secondary | Left ventricular ejection fraction assessed both preoperative and after 24 hours postoperatively. | assessed both preoperative and after 24 hours postoperatively. | echo assessment |
| Secondary | Preoperative EURO II score | assessed preoperatively at the start of patient enrollment | EURO II score |
| Secondary | Inotropic support. | assessed after patient is transferred to intensive care up to 6 hours from start of surgery | the need for inotropes on transfer to intensive care |
| Secondary | Total time of inotropes or vasopressor requirement in hours | assessed after patient is weaned from inotropes up to one month | the need for inotropes in intensive care |
| Secondary | CK-MB (U/L) . | at immediate postoperatively, 12 and 24 hours after surgery | CK-MB (U/L) . |
| Secondary | Serum lactate level | at immediate postoperatively, 12 and 24 hours after surgery. | Serum lactate level |
| Secondary | Incidence of postoperative Myocardial infarction | assessed from icu admission until discharge up to one month | Incidence of postoperative Myocardial infarction |
| Secondary | Incidence of postoperative Atrial fibrillations | assessed from icu admission until ICU discharge up to one month | Incidence of postoperative Atrial fibrillations |
| Secondary | Time for weaning from mechanical ventilation | assessed from icu admission until ventilator weaning up to one month | from mechanical ventilation (in hours). |
| Secondary | ICU length of stay | assessed from icu admission until ICU discharge up to one month | in hours |
| Secondary | hospital length of stay (in days) | assessed from icu admission until home discharge up to one month | in days |
| Secondary | Mortality rate | assessed up to one month postoperatively | Mortality rate |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07205757/registered